Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous ACB vs Single Shot ACB + ER Hydromorphone in TKA
NCT03990038Terminated
- Start
- Aug 2019
- Primary completion
- Oct 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of hydromorphone in postoperative pain (2 arms). Primary endpoint: Pain score during walking at 24 hours. Started Aug 2019; status: terminated.
02
Drugs
hydromorphone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03990038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03990038.